Mazen Noureddin, MD, MHSc, is a Professor of Medicine and internationally recognized expert in Steatotic Liver Disease (SLD) and SLD-related cirrhosis. He has led over 80 clinical trials, advanced non-invasive diagnostics and biomarkers, and serves on major liver society panels, editorial boards, and industry advisory committees. Currently at Houston Methodist Hospital, he directs the Houston Research Institute and serves as Chief Scientific Officer for Summit and Pinnacle Clinical Research.